← See the report
Jornalista.ai
Who didn't tell you
Anvisa approves new indication for Enhertu in HER2-positive breast cancer
Approval documented in Resolution RE No. 1.991, of May 14, 2026
Reported by:
Otempo
2 outlets didn't cover this
JC
Jornal GGN
2 sources · jornalista.ai
Screenshot it and send it to the group.